NovAccess Global XSNX Stock
0.01 USD
{{ price }}
-6.818179%
{{change_pct}}%
SECTOR
Healthcare
INDUSTRY
Biotechnology
COUNTRY
United States
Exchange
Other OTC
Market Cap
283.65K USD
LOW - HIGH [24H]
0.0090
-
0.01 USD
VOLUME [24H]
847.76K USD
{{ volume }}
P/E Ratio
0
Earnings per share
-0.08 USD
NovAccess Global Price Chart
NovAccess Global XSNX Financial and Trading Overview
| NovAccess Global stock price | 0.01 USD |
| Previous Close | 0.14 USD |
| Open | 0.14 USD |
| Bid | 0 USD x 0 |
| Ask | 0 USD x 0 |
| Day's Range | 0.14 - 0.14 USD |
| 52 Week Range | 0.11 - 0.6 USD |
| Volume | 2 USD |
| Avg. Volume | 6.86K USD |
| Market Cap | 2.99M USD |
| Beta (5Y Monthly) | 1.534859 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.08 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
XSNX Valuation Measures
| Enterprise Value | 9.14M USD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | N/A |
Trading Information
NovAccess Global Stock Price History
| Beta (5Y Monthly) | 1.534859 |
| 52-Week Change | 15.00% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 0.6 USD |
| 52 Week Low | 0.11 USD |
| 50-Day Moving Average | 0.15 USD |
| 200-Day Moving Average | 0.19 USD |
XSNX Share Statistics
| Avg. Volume (3 month) | 6.86K USD |
| Avg. Daily Volume (10-Days) | 4.84K USD |
| Shares Outstanding | 21.19M |
| Float | 10.37M |
| Short Ratio | N/A |
| % Held by Insiders | 51.03% |
| % Held by Institutions | 9.18% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:1000 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | September 30, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | September 30, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -1464.49% |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | N/A |
| Net Income Avi to Common (ttm) | -2520508 USD |
| Diluted EPS (ttm) | -0.11 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 21.99K USD |
| Total Cash Per Share (mrq) | 0.001 USD |
| Total Debt (mrq) | 1.96M USD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 0.018 |
| Book Value Per Share (mrq) | -0.469 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -821155 USD |
| Levered Free Cash Flow (ttm) | 61.5K USD |
Profile of NovAccess Global
| Country | United States |
| State | OH |
| City | Chagrin Falls |
| Address | 8584, Washington Street |
| ZIP | 44023 |
| Phone | 213 642 9268 |
| Website | https://novaccessglobal.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 2 |
NovAccess Global Inc., a biopharmaceutical company, develops novel immunotherapies to treat brain tumor patients in the United States. The company specializes in cutting-edge research related to utilizing a patient's immune system to attack the cancer. NovAccess Global Inc. was incorporated in 1997 and is headquartered in Chagrin Falls, Ohio.
Q&A For NovAccess Global Stock
What is a current XSNX stock price?
NovAccess Global XSNX stock price today per share is 0.01 USD.
How to purchase NovAccess Global stock?
You can buy XSNX shares on the Other OTC exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for NovAccess Global?
The stock symbol or ticker of NovAccess Global is XSNX.
Which industry does the NovAccess Global company belong to?
The NovAccess Global industry is Biotechnology.
How many shares does NovAccess Global have in circulation?
The max supply of NovAccess Global shares is 27.54M.
What is NovAccess Global Price to Earnings Ratio (PE Ratio)?
NovAccess Global PE Ratio is now.
What was NovAccess Global earnings per share over the trailing 12 months (TTM)?
NovAccess Global EPS is -0.08 USD over the trailing 12 months.
Which sector does the NovAccess Global company belong to?
The NovAccess Global sector is Healthcare.